Evento
Fluorinated oxysterol analogues: Synthesis, molecular modelling and liver X receptor activity
Rodriguez, Cristian Ramon
; Alvarez, Lautaro Damian
; Dansey, Maria Virginia
; Paolo, Luciano Sebastián; Veleiro, Adriana Silvia
; Pecci, Adali
; Burton, Gerardo
Tipo del evento:
Simposio
Nombre del evento:
17th Tetrahedron Symposium: Challenges in Biological, Bioorganic, Organic & Medicinal Chemistry
Fecha del evento:
28/06/2016
Institución Organizadora:
Elsevier;
Título del Libro:
Libro de resúmenes
Título de la revista:
The Journal of Steroid Biochemistry and Molecular Biology
Editorial:
Pergamon-Elsevier Science Ltd
ISSN:
0960-0760
Idioma:
Inglés
Clasificación temática:
Resumen
Liver X receptors (LXRs) are nuclear receptors that play central roles in the transcriptional control of lipid metabolism. They also modulate immune and inflammation responses in macrophagues and have multiple roles in cancer biology. The ability of LXRs to integrate metabolic and inflammation signaling makes them particularly attractive targets for intervention in human metabolic diseases. The undesirable effect of LXR agonists on hepatic lipogenesis has prompted the development of LXR antagonists and inverse agonists.2 Several cholestenoic acids are endogenous LXR ligands (e.g. 25R-cholestenoic acid (1)),3 recently we showed that compound 2, a 27-nor analogue of 1, is an inverse agonist and antagonist of LXRs. We have now prepared two fluorinated analogues 3 and 4 from the readily available aldehyde 5. The key step was a Reformatsky reaction with ethyl bromodifluoroacetate under high intensity ultrasound (HIU) irradiation, followed by a BartonMcCombie type deoxygenation to give difluoroester 6 (scheme). LXR activity was evaluated in a luciferase reporter assay in HEK293T cells co-transfected with full length human LXRa and LXRb. At 10 uM the difluoroacid 3 was an inverse agonist and antagonist, similar to its nonfluorinated analog 2, while the difluoroalcohol 4 was an agonist. To investigate the molecular basis of action of ligands 3 and 4, we performed molecular dynamics simulations in our model of LXR.4 The LXR-4 complex maintained a stable agonist conformation similar to that of LXR-GW3965 complex (synthetic agonist) with both fluorine atoms and the 26-hydroxyl alternating in the interaction with His-435. A major change was observed for the LXR-3 complex although different to that observed with inverse agonist 2: Helix-11 is destabilized changing the secondary structure in this region of LXR that carries part of the AF-2 domain (where coactivators and corepressors bind), but without affecting the position of helix-12
Palabras clave:
FLUOROSTEROLS
,
LIVER X RECEPTOR
,
LXR
,
CHOLESTENOIC ACID
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos(IFIBYNE)
Eventos de INST.DE FISIOL., BIOL.MOLECULAR Y NEUROCIENCIAS
Eventos de INST.DE FISIOL., BIOL.MOLECULAR Y NEUROCIENCIAS
Eventos(UMYMFOR)
Eventos de UNID.MICROANAL.Y MET.FISICOS EN QUIM.ORG.(I)
Eventos de UNID.MICROANAL.Y MET.FISICOS EN QUIM.ORG.(I)
Citación
Fluorinated oxysterol analogues: Synthesis, molecular modelling and liver X receptor activity; 17th Tetrahedron Symposium: Challenges in Biological, Bioorganic, Organic & Medicinal Chemistry; Barcelona; España; 2016; 268-276
Compartir
Altmétricas